Format

Send to

Choose Destination
Cancer Cell. 2010 Jul 13;18(1):7-8. doi: 10.1016/j.ccr.2010.06.006.

The molecular biology of myeloproliferative disorders.

Author information

1
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. jradich@fhcrc.org

Abstract

The myeloproliferative disorders (MPDs) are a spectrum of clonal disorders of the hematopoietic system. The discovery of activating mutations of the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and primary myelofibrosis has lead to in vitro and animal model studies that promise to lead to therapeutic advances.

PMID:
20609348
DOI:
10.1016/j.ccr.2010.06.006
Free full text

Publication type

Publication type

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center